DT
CRL icon

Diversified Trust’s Charles River Laboratories CRL Stock Holding History

Diversified Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
+1,319
New +$235K ﹤0.01% 910
2021
Q1 		– Sell
-931
Closed -$233K – 784
2020
Q4 		$233K Buy
+931
New +$222K 0.01% 605

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MPPW
Mitchell & Pahl Private Wealth Oklahoma City, Oklahoma $272M AUM 29.72% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Diversified Trust's CRL Position: Q2 2026 in Review

Diversified Trust opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,319 shares worth $299K. The stake represents ﹤0.01% of the portfolio and ranks #910 among its holdings. This is a return to the name: Diversified Trust previously reported a position in CRL as recently as Q4 2020.

Diversified Trust first reported a position in CRL in Q4 2020 and has held it in 2 quarters since. 62 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Diversified Trust held 1,319 shares of Charles River Laboratories worth $299K as of Q2 2026.
  • Charles River Laboratories was a new Diversified Trust position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #910 holding.
  • Diversified Trust first reported a position in Charles River Laboratories in Q4 2020 and has held it in 2 quarters since.
  • 62 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.